FR104

2 Cited Publications
Revisión del cliente

Based on 2 publication(s) in Google Scholar

FR104 is a selective CD28 inhibitor (binding to CD28 with a Kd value of 4.6 nM; ED50 value of 7.5 ng/mL). FR104 blocks the binding of CD28 to CD80/CD86 and ICOSL, inhibiting conventional T cell costimulation, proliferation, IL-2 secretion, alloantigen responses, and donor-specific alloantibody production. FR104 does not affect the CTLA-4/PD-L1 pathway, preserves the suppressive function of regulatory T cells, and accumulates Helios-negative Foxp3-positive regulatory T cells. FR104 has a prolonged half-life via pegylation (PEG300) (HY-Y0873) and sustained receptor occupancy, and alleviates central nervous system inflammation, demyelinating lesions, and anti-rhMOG responses. FR104 can be used for research on graft-versus-host disease, renal allograft rejection, and experimental autoimmune encephalomyelitis.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza : 97.26%
  • Peso molecular:145.08 kDa
  • Almacenamiento:
    Shipping with dry ice

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Actividad biológica
  • Chemical Information
  • Protocolo
  • Pureza y Documentación
  • Referencias
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) FR104

More

Ver todos los productos específicos de isoformas Interleukin Related

More
MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00